Back to (non-)Basics: An Update on Neutral and Charge-Balanced Glycosidase Inhibitors

Mini Rev Med Chem. 2018;18(10):812-827. doi: 10.2174/1389557517666171002161325.

Abstract

Glycosidases have important anti-cancer, anti-viral and anti-diabetic properties. This review covers the literature in the past 15 years since our initial review in this journal on "neutral" glycosidase inhibitors lacking a basic nitrogen found in iminosugars and azasugars or inhibitors that are neutral by virtue of being "charge-balanced" (zwitterionic). These structurally diverse inhibitors include lactones, lactams, epoxides such as cyclophellitol, and sulfonium ion derivatives of the natural product salacinol. Synthetic efforts toward cyclophillitol, salicinol and derivatives are also highlighted. Importantly, certain metals can inhibit glycosidases and care must be taken to remove residual catalysts from synthetic material to be tested against these enzymes.

Keywords: Cadmium; X-ray crystallography; computational; copper; cyclophellitol; deoxynojirimycin; diabetes; electrophilic; epoxide; fucosidase; galactosidase; glucocerebroside; glucosidase; glycal; homology; hydantocidin; iminosugar; lactam; lactone; mannosidase; metal complex; modeling; molybdenum; natural product; palladium; salacinol; sialidase; silver; transition-state mimic; vanadium; zinc..

Publication types

  • Review

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Glycoside Hydrolases / antagonists & inhibitors*
  • Glycoside Hydrolases / metabolism
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Glycoside Hydrolases